Manulife (Manufacturers Life Insurance)
FHTX icon

Manulife (Manufacturers Life Insurance)’s Foghorn Therapeutics FHTX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,295
Closed -$48.6K – 2928
2024
Q4 		$48.6K Sell
10,295
-265
-3% -$1.93K ﹤0.01% 2938
2024
Q3 		$98.3K Sell
10,560
-640
-6% -$4.63K ﹤0.01% 2873
2024
Q2 		$64.4K Buy
+11,200
New +$66.7K ﹤0.01% 2930
2022
Q1 		– Sell
-10,246
Closed -$234 – 3107
2021
Q4 		$234 Buy
+10,246
New +$147K ﹤0.01% 2795

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s FHTX Position: Q1 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Foghorn Therapeutics (FHTX) in Q1 2025, closing a stake of 10,295 shares — an estimated $48.6K sold.

Manulife (Manufacturers Life Insurance) first reported a position in FHTX in Q4 2021 and held it in 4 quarters. The position peaked at $98.3K in Q3 2024. 90 funds tracked by Wall St. Rank hold FHTX as of Q1 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining Foghorn Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 10,295 Foghorn Therapeutics shares in Q1 2025, an estimated $48.6K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Foghorn Therapeutics in Q4 2021 and held it in 4 quarters.
  • Manulife (Manufacturers Life Insurance)'s Foghorn Therapeutics position peaked at $98.3K in Q3 2024.
  • 90 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2025, filed 15 May 2025.